First Light Asset Management, LLC Centessa Pharmaceuticals PLC Transaction History
First Light Asset Management, LLC
- $780 Million
- Q1 2025
A detailed history of First Light Asset Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, First Light Asset Management, LLC holds 4,874,124 shares of CNTA stock, worth $66.4 Million. This represents 8.99% of its overall portfolio holdings.
Number of Shares
4,874,124
Previous 5,805,184
16.04%
Holding current value
$66.4 Million
Previous $97.2 Million
27.92%
% of portfolio
8.99%
Previous 9.51%
Shares
5 transactions
Others Institutions Holding CNTA
# of Institutions
140Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$272 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$136 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$132 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$94.7 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$80.7 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.28B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...